Sun Pharma open to large acquisitions post Ranbaxy.
Maharashtra Chief Minister Devendra Fadnavis on Saturday allocated portfolios to the twenty-member council of ministers, including 10 of the Shiv Sena, who were inducted into his expanded cabinet.
The FDA actions eventually led to a $500-million fine for Ranbaxy as well as the effective mothballing of many of its Indian factories.
Earlier in April, Pfizer said that it had offered a not-for-profit price for its vaccine for the government immunisation programme in India and it remains committed to continuing engagement with the government to make the vaccine available in India.
Maharashtra Chief Minister Devendra Fadnavis on Saturday allocated portfolios to newly sworn-in ministers and reshuffled certain portfolios.
Nestle was perceived as being feeble in its defence.
The first two coaches that rolled out from the Railway Coach Factory in Kapurthala also have fixtures coated with titanium dioxide and the provision for plasma air equipment in AC ducts to sterilise interiors using ionised air. Railway Minister Piyush Goyal also indicated that the new coaches could be the new normal.
Maharashtra's Food and Drugs Administration on Wednesday argued in the Bombay High Court that Nestle India.
The results reported from the observational studies, on average, show that vaccination had 95 per cent efficacy against severe disease both from the Delta variant and from the Alpha variant, and over 80 per cent efficacy at protecting against any infection from these variants.
Top 5 losers include Lupin, Cipla, Sun Pharma, Dr Reddy's Lab and GAIL down 1.6%-11%.
The central government has said it will look into the matter.
The novel coronavirus has mutated before, and both companies say they've found that their vaccines worked against other variations of the virus.
.jpg)
The company has been reported to be retrenching staff.
Can Interferon alfa-2b treat COVID-19 effectively?
The previous single-day record was on May 7 at 2,769 deaths.
Giuliani, 76, has been taken to the Medstar Georgetown University Hospital in Washington DC, according to US media reports.
We are surrounded by food that is contaminated, adulterated and does not meet Indian safety and packaging standards, says Abheet Singh Sethi/IndiaSpend.com.
US, the largest market for Indian shrimp exporters, is peeved over the use of banned antibiotics.
Nestle India has been arguing that ban order was arbitrary.
On her maiden visit to India, US Food and Drug Administrator Margaret A Hamburg has said recent lapses in quality by a handful of pharma companies has overshadowed the good things done by other Indian companies, who emphasise on quality products and practices.
He said action was akin to holding highway builders responsible for lane violations
"Confidence in the vaccine is what brings us here this morning," the US vice-president said in remarks following his vaccination. "I didn't feel a thing. Well done."
Pharma major Ranbaxy Laboratories has set aside Rs 257.4 crore (Rs 2.57 billion) towards the financial impact of a US ban on import of products made at its plant at Toansa.
Overall, the credit profiles of players will be supported by healthy balance sheets and liquidity. Prudence in capital and development expenditure, efficient working-capital management, and recent equity raising will help sustain credit metrics in FY22.
China has given conditional approval for a single dose COVID-19 vaccine, touted to be a rival to Johnson & Johnson's one-jab shot cleared by the United States drug regulator on Sunday.
'You ain't seen anything yet,' EAM Jaishankar says about the India-US relationship.
The first drug to treat low sexual desire in premenopausal women, dubbed "female Viagra", has been approved in the United States, but with a warning about potentially dangerous side effects such as severe low blood pressure and fainting.
In India, thousands of lives are lost every year because of unavailability of organs
The Covid-19 vaccine demonstrated an overall 90.4 per cent efficacy in phase 3 clinical trials, reports Sohini Das
The news comes as the United States approaches 300,000 deaths from COVID-19.
Sun Pharma to retain these in most markets; US could be the exception, where the Ranbaxy name has taken a hit.
This time food regulators found excess presence of ash content in Maggi
Guterres reiterated his call for a COVID-19 vaccine to be a global public good available to everywhere and particularly, available in Africa.
Pfizer can show the FDA approval to the Indian regulator and present a case that based on whatever data submitted, the US regulator has granted a full marketing nod, says Sohini Das.
Facing accusations of delay in placing orders for vaccines, the government on Thursday defended its vaccine procurement policy saying it has been pursuing Pfizer, J&J and Moderna since mid-2020 for the earliest possible imports, and has even waived local trials for well-established foreign vaccine makers.
Calling for 'equal recognition of vaccines', COVAX on Thursday urged all governments to recognise as 'fully vaccinated' those people who have received COVID-19 vaccines deemed safe by World Health Organisation, saying any move that restricts travel of people based on the vaccines they have received is 'counter-effective, both in spirit and outcome'.
On October 2, a legislature committee wrote letters to the 14 companies, initiating an investigation and seeking details about recent price increases in several generic products available in the American market.
A single-member commission under retired judge Anita Jha was constituted on Firday to probe the botched sterilisation surgeries at Bilaspur's government-run medical camps, which have so far claimed lives of 13 young women and left nearly 138 ill, and asked to submit its report within three months.
Fast Moving Consumer Goods major Nestle may face more action by the Uttar Pradesh Food Safety and Drug Administration, which is testing more batches of Maggi after ordering recall of a batch of about 2 lakh packs of the instant noodles due to higher than permitted levels of lead and a food additive.
The company has launched only 3 new products during 2015 when compared to 14 launches in 2014
